Placebo and Nocebo Effects | Research & References
The placebo and nocebo effects demonstrate the powerful influence of expectations, context, and therapeutic interaction on health outcomes. A placebo effect occurs when positive expectations lead to measurable improvements in symptoms, even when an inactive treatment is administered. Conversely, a nocebo effect occurs when negative expectations contribute to worsening symptoms or the experience of side effects.
Modern neuroscience and clinical research show that placebo and nocebo responses are not “imaginary” effects, but involve identifiable neurobiological mechanisms, including activation of endogenous opioid systems, dopamine pathways, and stress-related processes. These effects are particularly well-documented in pain, depression, anxiety, and neurological disorders. Understanding placebo and nocebo mechanisms is essential for ethical clinical practice, informed consent, therapeutic communication, and patient-centered care.
The studies below summarize key findings on the biological, psychological, and clinical mechanisms underlying placebo and nocebo responses.
Neurobiology of the Placebo Effect | Endogenous Opioids and Dopamine
Research demonstrates that placebo analgesia is associated with activation of endogenous opioid systems and dopamine release in brain regions involved in reward and pain modulation.
Benedetti, F., Mayberg, H. S., Wager, T. D., Stohler, C. S., & Zubieta, J.-K. (2005). Neurobiological mechanisms of the placebo effect. Journal of Neuroscience, 25(45), 10390–10402. https://doi.org/10.1523/JNEUROSCI.3458-05.2005
Scott, D. J., Stohler, C. S., Egnatuk, C. M., Wang, H., Koeppe, R. A., & Zubieta, J.-K. (2008). Placebo and nocebo effects are defined by opposite opioid and dopaminergic responses. Archives of General Psychiatry, 65(2), 220–231. https://doi.org/10.1001/archgenpsychiatry.2007.34
These studies demonstrate measurable brain changes during placebo responses, confirming that placebo effects involve real physiological processes.
Clinical Significance of Placebo Effects | Systematic Reviews
Meta-analyses have examined the magnitude of placebo effects across conditions.
Hróbjartsson, A., & Gøtzsche, P. C. (2010). Placebo interventions for all clinical conditions. Cochrane Database of Systematic Reviews, (1), CD003974. https://doi.org/10.1002/14651858.CD003974.pub3
This large Cochrane review found that placebo effects are generally small but can be clinically relevant for subjective outcomes such as pain and nausea.
Finniss, D. G., Kaptchuk, T. J., Miller, F., & Benedetti, F. (2010). Biological, clinical, and ethical advances of placebo effects. The Lancet, 375(9715), 686–695. https://doi.org/10.1016/S0140-6736(09)61706-2
This review highlights placebo effects as psychobiological events influenced by context, patient–provider interaction, and expectation.
Nocebo Effects and Negative Expectations
Nocebo effects occur when negative expectations increase symptom perception or produce adverse effects.
Benedetti, F., Lanotte, M., Lopiano, L., & Colloca, L. (2007). When words are painful: Unraveling the mechanisms of the nocebo effect. Neuroscience, 147(2), 260–271. https://doi.org/10.1016/j.neuroscience.2007.02.020
This study demonstrates that verbal suggestions of increased pain can activate anxiety-related pathways and enhance pain perception.
Colloca, L., & Barsky, A. J. (2020). Placebo and nocebo effects. New England Journal of Medicine, 382(6), 554–561. https://doi.org/10.1056/NEJMra1907805
This review emphasizes the clinical importance of communication, informed consent framing, and expectation management in minimizing nocebo responses.
Open-Label Placebos
Emerging research shows that placebos may still produce benefits even when patients are informed that they are receiving a placebo.
Kaptchuk, T. J., Friedlander, E., Kelley, J. M., Sanchez, M. N., Kokkotou, E., Singer, J. P., … Lembo, A. J. (2010). Placebos without deception: A randomized controlled trial in irritable bowel syndrome. PLoS ONE, 5(12), e15591. https://doi.org/10.1371/journal.pone.0015591
This study found that open-label placebo treatment led to symptom improvement compared to no treatment, suggesting expectation and ritual play powerful roles in healing processes.
Research & Resources
Benedetti, F., Lanotte, M., Lopiano, L., & Colloca, L. (2007). When words are painful: Unraveling the mechanisms of the nocebo effect. Neuroscience, 147(2), 260–271. https://doi.org/10.1016/j.neuroscience.2007.02.020
Benedetti, F., Mayberg, H. S., Wager, T. D., Stohler, C. S., & Zubieta, J.-K. (2005). Neurobiological mechanisms of the placebo effect. Journal of Neuroscience, 25(45), 10390–10402. https://doi.org/10.1523/JNEUROSCI.3458-05.2005
Colloca, L., & Barsky, A. J. (2020). Placebo and nocebo effects. New England Journal of Medicine, 382(6), 554–561. https://doi.org/10.1056/NEJMra1907805
Finniss, D. G., Kaptchuk, T. J., Miller, F., & Benedetti, F. (2010). Biological, clinical, and ethical advances of placebo effects. The Lancet, 375(9715), 686–695. https://doi.org/10.1016/S0140-6736(09)61706-2
Hróbjartsson, A., & Gøtzsche, P. C. (2010). Placebo interventions for all clinical conditions. Cochrane Database of Systematic Reviews, (1), CD003974. https://doi.org/10.1002/14651858.CD003974.pub3
Kaptchuk, T. J., Friedlander, E., Kelley, J. M., Sanchez, M. N., Kokkotou, E., Singer, J. P., … Lembo, A. J. (2010). Placebos without deception: A randomized controlled trial in irritable bowel syndrome. PLoS ONE, 5(12), e15591. https://doi.org/10.1371/journal.pone.0015591
Scott, D. J., Stohler, C. S., Egnatuk, C. M., Wang, H., Koeppe, R. A., & Zubieta, J.-K. (2008). Placebo and nocebo effects are defined by opposite opioid and dopaminergic responses. Archives of General Psychiatry, 65(2), 220–231. https://doi.org/10.1001/archgenpsychiatry.2007.34